ISDA

Deposition Date 2015-07-09

Release Date 2015-08-12

Last Version Date 2024-11-20

Entry Detail

PDB ID:

5CGC

Keywords:

SIGNALING PROTEIN

Title:

Structure of the human class C GPCR metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator 3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin-4-yl]benzonitrile

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)
Enterobacteria phage T4 (Taxon ID: 10665)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

3.10 Å

R-Value Free:

0.28

R-Value Work:

0.23

R-Value Observed:

0.23

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Metabotropic glutamate receptor 5,Endolysin,Metabotropic glutamate receptor 5
Gene (Uniprot):E, GRM5
Mutations:E579A N667Y I669A G675M C1054T C1097A T742A S753A,E579A N667Y I669A G675M C1054T C1097A T742A S753A,E579A N667Y I669A G675M C1054T C1097A T742A S753A
Chain IDs:A
Chain Length:444
Number of Molecules:1
Biological Source:Homo sapiens, Enterobacteria phage T4

UniProt ID:P41594,P00720 Pfam ID:PF00003, PF00959 EC:3.2.1.17

Ligand Molecules

51D

MES

OLA

Primary Citation

Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).

Christopher, J.A, Aves, S.J, Bennett, K.A, Dore, A.S, Errey, J.C, Jazayeri, A, Marshall, F.H, Okrasa, K, Serrano-Vega, M.J, Tehan, B.G, Wiggin, G.R, Congreve, M, Dore, A.S, Okrasa, K, Patel, J.C, Serrano-Vega, M, Bennett, K, Cooke, R.M, Errey, J.C, Jazayeri, A, Khan, S, Tehan, B, Weir, M, Wiggin, G.R, Marshall, F.H.Show

J.Med.Chem. 58 6653 6664 (2015)

PMID: 26225459 DOI: 10.1021/acs.jmedchem.5b00892

Abstact

Fragment screening of a thermostabilized mGlu5 receptor using a high-concentration radioligand binding assay enabled the identification of moderate affinity, high ligand efficiency (LE) pyrimidine hit 5. Subsequent optimization using structure-based drug discovery methods led to the selection of 25, HTL14242, as an advanced lead compound for further development. Structures of the stabilized mGlu5 receptor complexed with 25 and another molecule in the series, 14, were determined at resolutions of 2.6 and 3.1 Å, respectively.

Legend

Protein

Chemical

Disease

Primary Citation of related structures